Chlorpheniramine Maleate; Ibuprofen; Pseudoephedrine Hydrochloride Patent Expiration
Chlorpheniramine Maleate; Ibuprofen; Pseudoephedrine Hydrochloride was first introduced by Haleon Us Holdings Llc
Chlorpheniramine Maleate; Ibuprofen; Pseudoephedrine Hydrochloride Patents
Given below is the list of patents protecting Chlorpheniramine Maleate; Ibuprofen; Pseudoephedrine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Advil Allergy Sinus | US7863287 | Compositions of non-steroidal anti-inflammatory drugs, decongestants and anti-histamines | Feb 28, 2027 | Haleon Us Holdings |
| Children's Advil Allergy Sinus | US10238640 | Pharmaceutical suspension composition |
May 25, 2024
(Expired) | Haleon Us Holdings |
Chlorpheniramine Maleate; Ibuprofen; Pseudoephedrine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List